奥雷巴替尼联合化疗治疗伴T315I 突变的Ph 阳性急性淋巴细胞白血病 3 例报道及文献复习
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 226, doi. 10.3872/j.issn.1007-385x.2025.02.012
- By:
- Publication type:
- Article
Works matching IS 1007385X AND DT 2025 AND VI 32 AND IP 2
Results: 12
1
2
氧化固醇参与肿瘤发生发展的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 219, doi. 10.3872/j.issn.1007-385x.2025.02.011
- By:
- Publication type:
- Article
3
靶向肿瘤相关脂肪微环境在乳腺癌治疗中的研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 213, doi. 10.3872/j.issn.1007-385x.2025.02.010
- By:
- Publication type:
- Article
4
STING在肿瘤微环境下的多重功能与临床价值.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 206, doi. 10.3872/j.issn.1007-385x.2025.02.009
- By:
- Publication type:
- Article
5
IL-1β 促癌及抑癌的双向调控机制研究进展.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 199, doi. 10.3872/j.issn.1007-385x.2025.02.008
- By:
- Publication type:
- Article
6
NLR、PLR、LDH联合检测对转移性胃癌免疫治疗的预后价值.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 189, doi. 10.3872/j.issn.1007-385x.2025.02.007
- By:
- Publication type:
- Article
7
食管鳞状细胞癌患者血清外泌体miR-1246 的表达及其临床意义.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 176, doi. 10.3872/j.issn.1007-385x.2025.02.006
- By:
- Publication type:
- Article
8
靶向趋化因子配体1 对口腔鳞状细胞癌细胞恶性生物学行为的影响.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 169, doi. 10.3872/j.issn.1007-385x.2025.02.005
- By:
- Publication type:
- Article
9
FOXD2-AS1 通过EZH2 调控LATS1 表达影响肾癌细胞的增殖与迁移.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 161, doi. 10.3872/j.issn.1007-385x.2025.02.004
- By:
- Publication type:
- Article
10
肿瘤源性外泌体hsa-miR-29c-3p 通过靶向ATAD2B调控宫颈鳞状细胞 癌的血管生成.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 151, doi. 10.3872/j.issn.1007-385x.2025.02.003
- By:
- Publication type:
- Article
11
WTAP通过m<sup>6</sup>A修饰增强MAP3K9 mRNA稳定性促进食管鳞状细胞癌 细胞的恶性生物学行为.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 140, doi. 10.3872/j.issn.1007-385x.2025.02.002
- By:
- Publication type:
- Article
12
CAR-T细胞精准治疗血液恶性肿瘤发展进程中的四大突破及其存在的 问题和解决对策
- Published in:
- Chinese Journal of Cancer Biotherapy, 2025, v. 32, n. 2, p. 127, doi. 10.3872/j.issn.1007-385x.2025.02.001
- By:
- Publication type:
- Article